RXRX Operating Cash Flow (Statement)
Recursion Pharmaceuticals Inc Clas · Operating Cash Flow (Statement)
RXRX Operating Cash Flow (Statement)
Latest reported-$350.48Mperiod ending
RXRX Cash from Operations (-$57.04M → -$350.48M)
Annual operating cash flow (statement)
High-resolution chart · PNG
RXRX operating cash flow (statement) history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -371,808,000 | |
| -359,174,000 | |
| -287,780,000 | |
| -83,524,000 | |
| -158,614,000 | |
| -45,399,000 | |
| -57,042,000 |